Olanzapine for Injection

About X-gen Pharmaceuticals DJB

XGen Pharmaceuticals DJB is a commercial-stage, revenue-generating generic drug company with a strategy centered on acquiring and marketing stable-volume, limited-competition generic products. The company emphasizes its core strengths in supply chain logistics, regulatory compliance, and customer relationships, aiming to add 3-5 new products to its portfolio annually. As a private, family-run business, it leverages its flexibility and decades of collective industry experience to navigate the competitive generic pharmaceuticals market, supported by recent milestones like NABP accreditation.

Therapeutic Areas

Other Psychiatric disorders Drugs